Ophthalmology

Top Story

FDA raises concerns about manufacturing deficiencies in Dextenza complete response letter

July 25, 2016

Ocular Therapeutix received a complete response letter from the FDA regarding the new drug application for Dextenza for the treatment of postoperative ocular pain, according to a press release.

The letter addresses the FDA’s concerns about the deficiencies in the manufacturing process and controls that were identified during a pre-NDA approval inspection of the company’s manufacturing facility, but the FDA did not provide details on which manufacturing deficiencies were identified.

Inotek receives US patent for trabodenoson, prostaglandin analogue for reduction of IOP

July 25, 2016
The United States Patent and Trademark Office has issued a composition of matter patent for trabodenoson in combination with a prostaglandin analogue for reducing IOP in…

Publication Exclusive: Pearls for residents, fellows as surgical training gets underway

July 25, 2016
During medical school there is relatively little exposure to ophthalmology, and only about 2% of all residency positions are devoted to our field. Training in…
Meeting News CoverageVideo

VIDEO: High-resolution OCT findings of macular disorders

July 24, 2016
At Retina 2016, Elias Reichel, MD, shares cases of high-resolution OCT findings of macular disorders from his practice.
Meeting News CoverageVideo

VIDEO: Speaker gives update on infectious uveitis

July 23, 2016
At Hawaiian Eye, Thomas A. Albini, MD, gives an update on infectious uveitis.
More News Headlines »
Original Article

Effects of Head-Mounted Display on the Oculomotor System and Refractive Error in Normal Adolescents

Journal of Pediatric Ophthalmology and Strabismus, July/August 2016, Volume 53 Issue 4
To investigate the clinical effects of head-mounted display on the refractive error and oculomotor system in normal…
More »
CME

Wet Macular Degeneration: A Review of Pivotal Clinical Trials

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology…
More »
Featured
Highlights from ASCRS

Highlights from ASCRS

Video
Meeting News Coverage

VIDEO: High-resolution OCT findings of macular disorders

July 24, 2016
More »
morganatic-roan